FDA Inspection 931077 — Strides House Bilekahalti

Strides House Bilekahalti — FEI 3010596238

The FDA completed an inspection of Strides House Bilekahalti on May 20, 2015 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 20, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bangalore (India)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.